Growth Factor Receptor-bound Protein 2 SH2/SH3 Domain Binding to CD28 and Its Role in Co-signaling
Open accessThe DOI matches its Crossref record.
Abstract
The co-stimulatory antigen CD28 has been shown to bind to several intracellular proteins including phosphatidylinositol 3-kinase, growth factor receptor-bound protein 2 (Grb2), and ITK. Paradoxically, Grb2 and phosphatidylinositol 3-kinase binding has been mapped to a similar pYMNM motif within the CD28 cytoplasmic tail. Given the importance of CD28 co-signaling to T cell function, questions exist regarding the mechanism by which Grb2 binds to CD28, and whether the interaction plays a role in co-stimulation. To biochemically characterize Grb2/CD28 binding, we initially utilized glutathione S-transferase-Grb2 fusion proteins carrying inactivating mutations within the SH2 and SH3 domains of Grb2, and assessed their ability to bind to CD28. In vitro binding experiments indicated that the Grb2 SH2 domain is critical for the association, while the SH3 domain plays an additional role in facilitating optimal binding. Enhanced binding via the SH3 domains was not observed when the C-terminal PXXP motif within CD28 was disrupted, thereby indicating that both SH2 and SH3 domains contribute to CD28 binding. Mutations that alter Grb2 binding were found to block the CD28-dependent interleukin-2 production. Further, tyrosine phosphorylation of Vav and the costimulation-dependent activation of Jun N-terminal kinase was blocked in cells defective in CD28/Grb2 binding. These results provide evidence for an alternate CD28-mediated signaling process involving Grb2 binding to the co-receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
CD28 Costimulation: From Mechanism to Therapy
Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A., & Bluestone, J. A. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.020 · Cited by 937
T Lymphocyte Costimulation Mediated by Reorganization of Membrane Microdomains
Viola, A., Schroeder, S., Sakakibara, Y., & Lanzavecchia, A. (1999) · Science · doi:10.1126/science.283.5402.680 · Cited by 938
T-cell regulation by CD28 and CTLA-4
Alegre, M.-L., Frauwirth, K. A., & Thompson, C. B. (2001) · Nature Reviews Immunology · doi:10.1038/35105024 · Cited by 914
CD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
“Inhibition of ERKs could account for negative signaling, while the activation of JNK could contribute to the effects of CTLA-4 on T-helper cell type 1 (Th1) versus Th2 cell differentiation, in which CTLA-4 and JNK1 have both been found to be required for Th1 cell differentiation (168).”
BackgroundSelf-citationPI3K in lymphocyte development, differentiation and activation
Okkenhaug, K., & Vanhaesebroeck, B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1056 · Cited by 810
PD-1 signaling in primary T cells
Riley, J. L. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00767.x · Cited by 778
CD28-mediated co-stimulation: a quantitative support for TCR signalling.
Acuto, O., & Michel, F. (2003) · Nature Reviews Immunology · doi:10.1038/nri1248 · Cited by 775
“T cells that express CD28 in which the Asn residue of the Tyr-Met-Asn-Met motif is mutated are co-stimulation defectiv”
BackgroundRegulatory and Signaling Properties of the Vav Family
Bustelo, X. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1461-1477.2000 · Cited by 505
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling.
Rudd, C. E., & Schneider, H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1131 · Cited by 392
Self-citationLee, S. E., Woo, K. M., Kim, S. Y., Kim, H.-M., Kwack, K., Lee, Z. H., & Kim, H.-H. (2002) · Bone · doi:10.1016/s8756-3282(01)00657-3 · Cited by 311
Self-citationUpshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., & Leibson, P. J. (2006) · Nature Immunology · doi:10.1038/ni1325 · Cited by 300
An Enigmatic Tail of CD28 Signaling
Boomer, J. S., & Green, J. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002436 · Cited by 283
“A role for the YMNM motif in IL-2 secretion was suggested using murine cell lines but whether this was mediated through Grb2 or PI3K was not clear (Pagès et al. 1994; Cai et al. 1995; Kim et al. 1998; Watanabe et al. 2006).”
BackgroundTumor Necrosis Factor-α Supports the Survival of Osteoclasts through the Activation of Akt and ERK
Lee, S. E., Chung, W. J., Kwak, H. B., Chung, C.-H., Kwack, K., Lee, Z. H., & Kim, H.-H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103642200 · Cited by 254
Self-citationA point mutation in CD28 distinguishes proliferative signals from survival signals.
Okkenhaug, K., Wu, L., Garza, K. M., La Rose, J., Khoo, W., Odermatt, B., Mak, T. W., Ohashi, P. S., & Rottapel, R. (2001) · Nature Immunology · doi:10.1038/86327 · Cited by 210
“It was initially proposed that Grb2 links CD28 to Ras signaling and more recently proposed that it is required for the phosphorylation of Vav and activation of JN”
BackgroundLewitzky, M., Kardinal, C., Gehring, N. H., Schmidt, E. K., Konkol, B., Eulitz, M., Birchmeier, W., Schaeper, U., & Feller, S. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204202 · Cited by 95
Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA
Gavrieli, M., & Murphy, K. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.036 · Cited by 85
Porciello, N., & Tuosto, L. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.004 · Cited by 61
Dennehy, K. M., Elias, F., Na, S.-Y., Fischer, K.-D., Hünig, T., & Lühder, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1363 · Cited by 45
“Vav is a major substrate of kinases activated during CD28 ligation (39), and such phosphorylation is dependent on the integrity of the Grb-2 binding site in CD28 (34).”
Background
Metadata
- Authors
- Kim, H.-H., Tharayil, M., & Rudd, C. E.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 273
- Issue
- 1
- Pages
- 296-301
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2011444716
- Cited by
- 133
- References
- 0
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.